{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T16:28:33Z","timestamp":1758040113199,"version":"3.44.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.ahj.2016.12.014","type":"journal-article","created":{"date-parts":[[2017,1,4]],"date-time":"2017-01-04T11:32:04Z","timestamp":1483529524000},"page":"83-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Right vEntricular Dysfunction in tEtralogy of Fallot: INhibition of the rEnin-angiotensin-aldosterone system (REDEFINE) trial: Rationale and design of a randomized, double-blind, placebo-controlled clinical trial"],"prefix":"10.1016","volume":"186","author":[{"given":"Jouke P.","family":"Bokma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiel M.","family":"Winter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esm\u00e9e M.","family":"Kornaat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hubert W.","family":"Vliegen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arie P.","family":"van Dijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joost P.","family":"van Melle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Folkert J.","family":"Meijboom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martijn C.","family":"Post","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline K.","family":"Berbee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aeilko H.","family":"Zwinderman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara J.M.","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berto J.","family":"Bouma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ahj.2016.12.014_bb0005","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/heartjnl-2013-304958","article-title":"Contemporary predictors of death and sustained ventricular tachycardia in patients with repaired tetralogy of Fallot enrolled in the INDICATOR cohort","volume":"100","author":"Valente","year":"2014","journal-title":"Heart"},{"issue":"16","key":"10.1016\/j.ahj.2016.12.014_bb0010","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1161\/CIRCULATIONAHA.112.104786","article-title":"Sudden cardiac death in adult congenital heart disease","volume":"126","author":"Koyak","year":"2012","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.ahj.2016.12.014_bb0015","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/eurheartj\/ehv550","article-title":"Preoperative thresholds for mid-to-late haemodynamic and clinical outcomes after pulmonary valve replacement in tetralogy of Fallot","volume":"37","author":"Bokma","year":"2016","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.ahj.2016.12.014_bb0020","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","article-title":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators","volume":"327","author":"Pfeffer","year":"1992","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.ahj.2016.12.014_bb0025","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1093\/eurheartj\/ehq249","article-title":"ESC guidelines for the management of grown-up congenital heart disease (new version 2010)","volume":"31","author":"Baumgartner","year":"2010","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.ahj.2016.12.014_bb0030","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ahj.2012.07.023","article-title":"The prevalence of adult congenital heart disease, results from a systematic review and evidence based calculation","volume":"164","author":"van der Bom","year":"2012","journal-title":"Am Heart J"},{"issue":"22","key":"10.1016\/j.ahj.2016.12.014_bb0035","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1161\/CIRCULATIONAHA.110.946343","article-title":"Temporal trends in survival to adulthood among patients born with congenital heart disease from 1970 to 1992 in Belgium","volume":"122","author":"Moons","year":"2010","journal-title":"Circulation"},{"issue":"11 Suppl","key":"10.1016\/j.ahj.2016.12.014_bb0040","first-page":"S201","article-title":"Randomized trial of pulmonary valve replacement with and without right ventricular remodeling surgery","volume":"122","author":"Geva","year":"2010","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.ahj.2016.12.014_bb0045","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1161\/CIRCULATIONAHA.114.009454","article-title":"Unnatural history of tetralogy of Fallot: prospective follow-up of 40 years after surgical correction","volume":"130","author":"Cuypers","year":"2014","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.ahj.2016.12.014_bb0050","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1093\/eurheartj\/ehq032","article-title":"Mortality in adult congenital heart disease","volume":"31","author":"Verheugt","year":"2010","journal-title":"Eur Heart J"},{"issue":"9215","key":"10.1016\/j.ahj.2016.12.014_bb0055","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/S0140-6736(00)02213-3","article-title":"Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial\u2014the Losartan Heart Failure Survival Study ELITE II","volume":"355","author":"Pitt","year":"2000","journal-title":"Lancet (Lond Engl)"},{"issue":"12","key":"10.1016\/j.ahj.2016.12.014_bb0060","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.amjcard.2006.07.049","article-title":"Normal reference values for the adult right ventricle by magnetic resonance imaging","volume":"98","author":"Tandri","year":"2006","journal-title":"Am J Cardiol"},{"issue":"33","key":"10.1016\/j.ahj.2016.12.014_bb0065","first-page":"1646","article-title":"National registry and DNA-bank of patients with congenital heart disease: the CONCOR-project","volume":"148","author":"Vriend","year":"2004","journal-title":"Ned Tijdschr Geneeskd"},{"issue":"9704","key":"10.1016\/j.ahj.2016.12.014_bb0070","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1016\/S0140-6736(09)61913-9","article-title":"Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial","volume":"374","author":"Konstam","year":"2009","journal-title":"Lancet (Lond Engl)"},{"issue":"5","key":"10.1016\/j.ahj.2016.12.014_bb0075","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.ahj.2010.08.005","article-title":"Rationale and design of a trial on the effect of angiotensin II receptor blockers on the function of the systemic right ventricle","volume":"160","author":"van der Bom","year":"2010","journal-title":"Am Heart J"},{"issue":"3","key":"10.1016\/j.ahj.2016.12.014_bb0080","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s10554-012-0112-7","article-title":"Impact of right ventricular endocardial trabeculae on volumes and function assessed by CMR in patients with tetralogy of Fallot","volume":"29","author":"Freling","year":"2012","journal-title":"Int J Cardiovasc Imaging"},{"issue":"3","key":"10.1016\/j.ahj.2016.12.014_bb0085","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/ehjci\/jev014","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"16","author":"Lang","year":"2015","journal-title":"Eur Heart J - Cardiovasc Imaging"},{"issue":"20","key":"10.1016\/j.ahj.2016.12.014_bb0090","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1161\/CIRCULATIONAHA.111.086983","article-title":"Left ventricular longitudinal function predicts life-threatening ventricular arrhythmia and death in adults with repaired tetralogy of Fallot","volume":"125","author":"Diller","year":"2012","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ahj.2016.12.014_bb0095","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4250\/jcu.2012.20.1.25","article-title":"Left atrial volume index as indicator of left ventricular diastolic dysfunction: comparation between left atrial volume index and tissue myocardial performance index","volume":"20","author":"Cacciapuoti","year":"2012","journal-title":"J Cardiovasc Ultrasound"},{"issue":"4","key":"10.1016\/j.ahj.2016.12.014_bb0100","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S0735-1097(85)80433-2","article-title":"An echocardiographic index for separation of right ventricular volume and pressure overload","volume":"5","author":"Ryan","year":"1985","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.ahj.2016.12.014_bb0105","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/ehjci\/jet105","article-title":"Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging","volume":"14","author":"Lancellotti","year":"2013","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"11","key":"10.1016\/j.ahj.2016.12.014_bb0110","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0895-4356(98)00097-3","article-title":"Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations","volume":"51","author":"Aaronson","year":"1998","journal-title":"J Clin Epidemiol"},{"issue":"12","key":"10.1016\/j.ahj.2016.12.014_bb0115","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0895-4356(03)00220-8","article-title":"Reproducibility and relative validity of the short questionnaire to assess health-enhancing physical activity","volume":"56","author":"Wendel-Vos","year":"2003","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"10.1016\/j.ahj.2016.12.014_bb0120","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","volume":"325","year":"1991","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ahj.2016.12.014_bb0125","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S0735-1097(02)02063-6","article-title":"Valsartan benefits left ventricular structure and function in heart failure: Val-HeFT echocardiographic study","volume":"40","author":"Wong","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2016.12.014_bb0130","article-title":"QRS fragmentation is superior to QRS duration in predicting mortality in adults with tetralogy of Fallot","author":"Bokma","year":"2016","journal-title":"Heart"},{"issue":"4","key":"10.1016\/j.ahj.2016.12.014_bb0135","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/jmri.24050","article-title":"Interstudy variability in cardiac magnetic resonance imaging measurements of ventricular volume, mass, and ejection fraction in repaired tetralogy of Fallot: a prospective observational study","volume":"38","author":"Blalock","year":"2013","journal-title":"J Magn Reson Imaging"},{"issue":"1","key":"10.1016\/j.ahj.2016.12.014_bb0140","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1161\/01.CIR.0000020009.30736.3F","article-title":"Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease","volume":"106","author":"Bolger","year":"2002","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ahj.2016.12.014_bb0145","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1161\/01.CIR.83.6.1849","article-title":"Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system","volume":"83","author":"Weber","year":"1991","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.ahj.2016.12.014_bb0150","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1440-1681.2003.03942.x","article-title":"Role of angiotensin AT1 and AT2 receptors in cardiac hypertrophy and cardiac remodelling","volume":"30","author":"Zhu","year":"2003","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"6","key":"10.1016\/j.ahj.2016.12.014_bb0155","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/heartjnl-2014-306398","article-title":"Neurohormonal activation and its relation to outcomes late after repair of tetralogy of Fallot","volume":"101","author":"Heng","year":"2015","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.ahj.2016.12.014_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcmg.2015.09.011","article-title":"Myocardial ECV fraction assessed by CMR is associated with type of hemodynamic load and arrhythmia in repaired tetralogy of Fallot","volume":"9","author":"Chen","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"issue":"2","key":"10.1016\/j.ahj.2016.12.014_bb0165","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1254\/jphs.09112FP","article-title":"Effects of telmisartan on right ventricular remodeling induced by monocrotaline in rats","volume":"111","author":"Okada","year":"2009","journal-title":"J Pharmacol Sci"},{"issue":"8","key":"10.1016\/j.ahj.2016.12.014_bb0170","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3109\/10641963.2010.503295","article-title":"Effects of atorvastatin and losartan on monocrotaline-induced pulmonary artery remodeling in rats","volume":"32","author":"Xie","year":"2010","journal-title":"Clin Exp Hypertens"},{"issue":"6","key":"10.1016\/j.ahj.2016.12.014_bb0175","doi-asserted-by":"crossref","first-page":"H2319","DOI":"10.1152\/ajpheart.00518.2005","article-title":"Prevention of pulmonary vascular remodeling and of decreased BMPR-2 expression by losartan therapy in shunt-induced pulmonary hypertension","volume":"289","author":"Rondelet","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"10.1016\/j.ahj.2016.12.014_bb0180","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0002-8703(97)70104-2","article-title":"Acute and long-term effects of the angiotensin-converting enzyme inhibitor, enalapril, on adrenergic activity and sensitivity during exercise in patients with left ventricular systolic dysfunction","volume":"134","author":"Patten","year":"1997","journal-title":"Am Heart J"},{"issue":"3","key":"10.1016\/j.ahj.2016.12.014_bb0185","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1161\/CIRCULATIONAHA.112.135392","article-title":"Effect of valsartan on systemic right ventricular function: a double-blind, randomized, placebo-controlled pilot trial","volume":"127","author":"van der Bom","year":"2013","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ahj.2016.12.014_bb0190","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ijcard.2010.09.057","article-title":"Randomised trial of ramipril in repaired tetralogy of Fallot and pulmonary regurgitation: the APPROPRIATE study (Ace inhibitors for Potential PRevention Of the deleterious effects of Pulmonary Regurgitation In Adults with repaired TEtralogy of Fallot)","volume":"154","author":"Babu-Narayan","year":"2012","journal-title":"Int J Cardiol"},{"issue":"10","key":"10.1016\/j.ahj.2016.12.014_bb0195","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1161\/CIRCULATIONAHA.108.816546","article-title":"Effects of regional dysfunction and late gadolinium enhancement on global right ventricular function and exercise capacity in patients with repaired tetralogy of Fallot","volume":"119","author":"Wald","year":"2009","journal-title":"Circulation"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870316302952?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870316302952?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:58:09Z","timestamp":1757570289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870316302952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":39,"alternative-id":["S0002870316302952"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2016.12.014","relation":{},"ISSN":["0002-8703"],"issn-type":[{"type":"print","value":"0002-8703"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Right vEntricular Dysfunction in tEtralogy of Fallot: INhibition of the rEnin-angiotensin-aldosterone system (REDEFINE) trial: Rationale and design of a randomized, double-blind, placebo-controlled clinical trial","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2016.12.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}